Ventricular Tachyarrhythmia (VT) Storm, Gene Expression in Implantable Cardioverter Defibrillator (ICD) Patients With Electrical Storm
Completed
Conditions studied: Arrhythmias
In brief
The purpose of the proposed pilot study is to identify factors which are associated with periods of high ventricular arrhythmia burden. This will be performed by analysis of gene expression from peripheral blood samples.
Key facts
- Study ID
- NCT00284453
- Run by
- University of Pittsburgh
- People needed
- 65
- Starts
- 2008-08-26
- Expected to finish
- 2018-12-01
- Last updated by the study team
- 2019-02-12
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- ICD patients at least 18 years of age that present within a 72 hour period: 1) > 2 therapies for ventricular arrhythmias; 2) 1-2 therapies for ventricular arrhythmias; 3) inappropriate therapies for ventricular arrhythmias
- Able to give informed consent
You may not qualify if…
- Inability to give informed consent
Where it is running
- UPMC Presbyterian Hospital — Pittsburgh, Pennsylvania, United States
- UPMC Shadyside Hospital — Pittsburgh, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.